Antiapoptotic activity of argon and xenon

Cell Cycle

Volumn 12, Issue 16, 2013, Pages 2636-2642

  Spaggiari, Sabrina ^a,b,c   Kepp, Oliver ^a,b,c   Rello Varona, Santiago ^a,b,c   Chaba, Kariman ^a,b,c   Adjemian, Sandy ^a,b,c   Pype, Jan ^d   Galluzzi, Lorenzo ^a,e,f   Lemaire, Marc ^d   Kroemer, Guido ^b,c,e,f,g  

^a Institut Gustave Roussy   (France)

^b INSTITUT GUSTAVE ROUSSY   (France)

^c UNIVERSITÉ PARIS SACLAY   (France)

^d AIR LIQUIDE   (France)

^e UNIVERSITÉ PARIS DESCARTES   (France)

^f CENTRE DE RECHERCHE DES CORDELIERS   (France)

^g HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

Antimycin A; Menadione; Mitochondrial membrane permeabilization; Rotenone; U2OS cells; Z VAD fmk

Indexed keywords

APOPTOSIS INHIBITOR; ARGON; CASPASE 3; CYTOCHROME C; HELIUM; KRYPTON; MITOXANTRONE; NEON; STAUROSPORINE; XENON;

APOPTOSIS; ARTICLE; AUTOMATION; CANCER CELL CULTURE; CELL LOSS; CELL PROTECTION; CELL VIABILITY; CONTROLLED STUDY; CYTOSOL; ENZYME ACTIVATION; ENZYME RELEASE; HUMAN; HUMAN CELL; IMAGE ANALYSIS; IMMUNOFLUORESCENCE MICROSCOPY; OSTEOSARCOMA CELL;

ANTIMYCIN A; MENADIONE; MITOCHONDRIAL MEMBRANE PERMEABILIZATION; ROTENONE; U2OS CELLS; Z-VAD-FMK;

APOPTOSIS; ARGON; CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; CELL SURVIVAL; CYTOCHROMES C; CYTOPROTECTION; HUMANS; MICROSCOPY, FLUORESCENCE; MITOXANTRONE; STAUROSPORINE; XENON;

EID: 84883207247     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.25650     Document Type: Article

References (48)

1. Hausenloy DJ, Yellon DM. The therapeutic potential of ischemic conditioning: an update. Nat Rev Cardiol 2011; 8:619-29; PMID:21691310; http://dx.doi.org/10.1038/nrcardio.2011.85
2. Gidday JM. Cerebral preconditioning and ischaemic tolerance. Nat Rev Neurosci 2006; 7:437-48; PMID:16715053; http://dx.doi.org/10.1038/nrn1927
3. Brücken A, Cizen A, Fera C, Meinhardt A, Weis J, Nolte K, et al. Argon reduces neurohistopathological damage and preserves functional recovery after cardiac arrest in rats. Br J Anaesth 2013; 110(Suppl 1):i106-12; PMID:23393152; http://dx.doi.org/10.1093/bja/aes509
4. Irani Y, Pype JL, Martin AR, Chong CF, Daniel L, Gaudart J, et al. Noble gas (argon and xenon)-saturated cold storage solutions reduce ischemia-reperfusion injury in a rat model of renal transplantation. Nephron Extra 2011; 1:272-82; PMID:22470401; http://dx.doi.org/10.1159/000335197
5. Ryang YM, Fahlenkamp AV, Rossaint R, Wesp D, Loetscher PD, Beyer C, et al. Neuroprotective effects of argon in an in vivo model of transient middle cerebral artery occlusion in rats. Crit Care Med 2011; 39:1448-53; PMID:21336110; http://dx.doi.org/10.1097/CCM.0b013e31821209be
6. Schiltz M, Fourme R, Broutin I, Prangé T. The catalytic site of serine proteinases as a specific binding cavity for xenon. Structure 1995; 3:309-16; PMID:7788296; http://dx.doi.org/10.1016/S0969-2126(01)00161-7
7. Preckel B, Weber NC, Sanders RD, Maze M, Schlack W. Molecular mechanisms transducing the anesthetic, analgesic, and organ-protective actions of xenon. Anesthesiology 2006; 105:187-97; PMID:16810011; http://dx.doi.org/10.1097/ 00000542-200607000-00029
8. Abraini JH, David HN, Lemaire M. Potentially neuroprotective and therapeutic properties of nitrous oxide and xenon. Ann N Y Acad Sci 2005; 1053:289-300; PMID:16179534; http://dx.doi.org/10.1196/annals.1344.025
9. Bickler PE, Warren DE, Clark JP, Gabatto P, Gregersen M, Brosnan H. Anesthetic protection of neurons injured by hypothermia and rewarming: roles of intracellular Ca2+ and excitotoxicity. Anesthesiology 2012; 117:280-92; PMID:22728782; http://dx.doi.org/10.1097/ALN.0b013e318260a7b9
10. Jawad N, Rizvi M, Gu J, Adeyi O, Tao G, Maze M, et al. Neuroprotection (and lack of neuroprotection) afforded by a series of noble gases in an in vitro model of neuronal injury. Neurosci Lett 2009; 460:232-6; PMID:19500647; http://dx.doi.org/10.1016/j.neulet.2009.05.069
11. Luo Y, Ma D, Ieong E, Sanders RD, Yu B, Hossain M, et al. Xenon and sevoflurane protect against brain injury in a neonatal asphyxia model. Anesthesiology 2008; 109:782-9; PMID:18946288; http://dx.doi.org/10.1097/ALN. 0b013e3181895f88
12. Ma D, Hossain M, Pettet GK, Luo Y, Lim T, Akimov S, et al. Xenon preconditioning reduces brain damage from neonatal asphyxia in rats. J Cereb Blood Flow Metab 2006; 26:199-208; PMID:16034370; http://dx.doi.org/10.1038/sj. jcbfm.9600184
13. Shu Y, Patel SM, Pac-Soo C, Fidalgo AR, Wan Y, Maze M, et al. Xenon pretreatment attenuates anesthetic-induced apoptosis in the developing brain in comparison with nitrous oxide and hypoxia. Anesthesiology 2010; 113:360-8; PMID:20613483; http://dx.doi.org/10.1097/ALN.0b013e3181d960d7
14. Faulkner S, Bainbridge A, Kato T, Chandrasekaran M, Kapetanakis AB, Hristova M, et al. Xenon augmented hypothermia reduces early lactate/N-acetylaspartate and cell death in perinatal asphyxia. Ann Neurol 2011; 70:133-50; PMID:21674582; http://dx.doi.org/10.1002/ana.22387
15. Yang T, Zhuang L, Rei Fidalgo AM, Petrides E, Terrando N, Wu X, et al. Xenon and sevoflurane provide analgesia during labor and fetal brain protection in a perinatal rat model of hypoxia-ischemia. PLoS One 2012; 7:e37020; PMID:22615878; http://dx.doi.org/10.1371/journal.pone.0037020
16. Li Q, Lian C, Zhou R, Li T, Xiang X, Liu B. Pretreatment with xenon protected immature rabbit heart from ischaemia/reperfusion injury by opening of the mitoKATP channel. Heart Lung Circ 2013; 22:276-83; PMID:23261327; http://dx.doi.org/10.1016/j.hlc.2012.10.016
17. Hein M, Roehl AB, Baumert JH, Bantes B, Bleilevens C, Bernstein N, et al. Establishment of a porcine right ventricular infarction model for cardioprotective actions of xenon and isoflurane. Acta Anaesthesiol Scand 2008; 52:1194-203; PMID:18823457; http://dx.doi.org/10.1111/j.1399-6576.2008.01757.x
18. Roehl AB, Funcke S, Becker MM, Goetzenich A, Bleilevens C, Rossaint R, et al. Xenon and isoflurane reduce left ventricular remodeling after myocardial infarction in the rat. Anesthesiology 2013; 118:1385-94; PMID:23364599; http://dx.doi.org/10.1097/ALN.0b013e31828744c0
19. Zhao H, Yoshida A, Xiao W, Ologunde R, O'Dea KP, Takata M, et al. Xenon treatment attenuates early renal allograft injury associated with prolonged hypothermic storage in rats. FASEB J 2013; PMID:23759444; http://dx.doi.org/10. 1096/fj.13-232173
20. Zhao H, Watts HR, Chong M, Huang H, Tralau-Stewart C, Maxwell PH, et al. Xenon Treatment Protects Against Cold Ischemia Associated Delayed Graft Function and Prolongs Graft Survival in Rats. Am J Transplant 2013; PMID:23710625; http://dx.doi.org/10.1111/ajt.12293
21. Bantel C, Maze M, Trapp S. Noble gas xenon is a novel adenosine triphosphate-sensitive potassium channel opener. Anesthesiology 2010; 112:623-30; PMID:20179498; http://dx.doi.org/10.1097/ALN.0b013e3181cf894a
22. Garlid KD, Halestrap AP. The mitochondrial K(ATP) channel-fact or fiction J Mol Cell Cardiol 2012; 52:578-83; PMID:22240339; http://dx.doi.org/10.1016/j. yjmcc.2011.12.011
23. Galluzzi L, Maiuri MC, Vitale I, Zischka H, Castedo M, Zitvogel L, et al. Cell death modalities: classification and pathophysiological implications. Cell Death Differ 2007; 14:1237-43; PMID:17431418; http://dx.doi.org/10.1038/sj.cdd. 4402148
24. Kroemer G, Galluzzi L, Vandenabeele P, Abrams J, Alnemri ES, Baehrecke EH, et al.; Nomenclature Committee on Cell Death 2009. Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009. Cell Death Differ 2009; 16:3-11; PMID:18846107; http://dx.doi.org/10.1038/cdd.2008. 150
25. Kroemer G, Galluzzi L, Brenner C. Mitochondrial membrane permeabilization in cell death. Physiol Rev 2007; 87:99-163; PMID:17237344; http://dx.doi.org/ 10.1152/physrev.00013.2006
26. Galluzzi L, Vitale I, Abrams JM, Alnemri ES, Baehrecke EH, Blagosklonny MV, et al. Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ 2012; 19:107-20; PMID:21760595; http://dx.doi.org/10.1038/cdd.2011.96
27. Vitale I, Galluzzi L, Castedo M, Kroemer G. Mitotic catastrophe: a mechanism for avoiding genomic instability. Nat Rev Mol Cell Biol 2011; 12:385-92; PMID:21527953; http://dx.doi.org/10.1038/nrm3115
28. Galluzzi L, Joza N, Tasdemir E, Maiuri MC, Hengartner M, Abrams JM, et al. No death without life: vital functions of apoptotic effectors. Cell Death Differ 2008; 15:1113-23; PMID:18309324; http://dx.doi.org/10.1038/cdd.2008.28
29. Galluzzi L, Blomgren K, Kroemer G. Mitochondrial membrane permeabilization in neuronal injury. Nat Rev Neurosci 2009; 10:481-94; PMID:19543220; http://dx.doi.org/10.1038/nrn2665
30. Feng G, Kaplowitz N. Mechanism of staurosporineinduced apoptosis in murine hepatocytes. Am J Physiol Gastrointest Liver Physiol 2002; 282:G825-34; PMID:11960779
31. Kepp O, Tesniere A, Zitvogel L, Kroemer G. The immunogenicity of tumor cell death. Curr Opin Oncol 2009; 21:71-6; PMID:19125021; http://dx.doi.org/10. 1097/CCO.0b013e32831bc375
32. Lindahl PE, Oberg KE. Mechanism of the physiological action of rotenone. Nature 1960; 187:784; PMID:14417054; http://dx.doi.org/10.1038/187784a0
33. Slater EC. The mechanism of action of the respiratory inhibitor, antimycin. Biochim Biophys Acta 1973; 301:129-54; PMID:4358868; http://dx.doi.org/10.1016/0304-4173(73)90002-5
34. Marchetti P, Susin SA, Decaudin D, Gamen S, Castedo M, Hirsch T, et al. Apoptosis-associated derangement of mitochondrial function in cells lacking mitochondrial DNA. Cancer Res 1996; 56:2033-8; PMID:8616847
35. Galluzzi L, Aaronson SA, Abrams J, Alnemri ES, Andrews DW, Baehrecke EH, et al. Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes. Cell Death Differ 2009; 16:1093-107; PMID:19373242; http://dx.doi.org/10.1038/cdd.2009.44
36. Kepp O, Galluzzi L, Lipinski M, Yuan J, Kroemer G. Cell death assays for drug discovery. Nat Rev Drug Discov 2011; 10:221-37; PMID:21358741; http://dx.doi.org/10.1038/nrd3373
37. Michaud M, Martins I, Sukkurwala AQ, Adjemian S, Ma Y, Pellegatti P, et al. Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice. Science 2011; 334:1573-7; PMID:22174255; http://dx.doi.org/10. 1126/science.1208347
38. Shen S, Niso-Santano M, Adjemian S, Takehara T, Malik SA, Minoux H, et al. Cytoplasmic STAT3 represses autophagy by inhibiting PKR activity. Mol Cell 2012; 48:667-80; PMID:23084476; http://dx.doi.org/10.1016/j.molcel.2012.09.013
39. Vitale I, Senovilla L, Jemaa M, Michaud M, Galluzzi L, Kepp O, et al. Multipolar mitosis of tetraploid cells: inhibition by p53 and dependency on Mos. EMBO J 2010; 29:1272-84; PMID:20186124; http://dx.doi.org/10.1038/emboj.2010.11
40. Cattano D, Williamson P, Fukui K, Avidan M, Evers AS, Olney JW, et al. Potential of xenon to induce or to protect against neuroapoptosis in the developing mouse brain. Can J Anaesth 2008; 55:429-36; PMID:18591700; http://dx.doi.org/10.1007/BF03016309
41. Brosnan H, Bickler PE. Xenon Neurotoxicity in Rat Hippocampal Slice Cultures Is Similar to Isoflurane and Sevoflurane. Anesthesiology 2013; PMID:23591069; http://dx.doi.org/10.1097/ALN.0b013e31829417f0
42. Criollo A, Senovilla L, Authier H, Maiuri MC, Morselli E, Vitale I, et al. IKK connects autophagy to major stress pathways. Autophagy 2010; 6:189-91; PMID:20110771; http://dx.doi.org/10.4161/auto.6.1.10818
43. Martins I, Kepp O, Schlemmer F, Adjemian S, Tailler M, Shen S, et al. Restoration of the immunogenicity of cisplatin-induced cancer cell death by endoplasmic reticulum stress. Oncogene 2011; 30:1147-58; PMID:21151176; http://dx.doi.org/10.1038/onc.2010.500
44. Rello-Varona S, Kepp O, Vitale I, Michaud M, Senovilla L, Jemaa M, et al. An automated fluorescence videomicroscopy assay for the detection of mitotic catastrophe. Cell Death Dis 2010; 1:e25; PMID:21364633; http://dx.doi.org/10. 1038/cddis.2010.6
45. de La Motte Rouge T, Galluzzi L, Olaussen KA, Zermati Y, Tasdemir E, Robert T, et al. A novel epidermal growth factor receptor inhibitor promotes apoptosis in non-small cell lung cancer cells resistant to erlotinib. Cancer Res 2007; 67:6253-62; PMID:17616683; http://dx.doi.org/10.1158/0008-5472.CAN-07- 0538
46. Hoffmann J, Vitale I, Buchmann B, Galluzzi L, Schwede W, Senovilla L, et al. Improved cellular pharmacokinetics and pharmacodynamics underlie the wide anticancer activity of sagopilone. Cancer Res 2008; 68:5301-8; PMID:18593931; http://dx.doi.org/10.1158/0008-5472.CAN-08-0237
47. Galluzzi L, Morselli E, Vitale I, Kepp O, Senovilla L, Criollo A, et al. miR-181a and miR-630 regulate cisplatin-induced cancer cell death. Cancer Res 2010; 70:1793-803; PMID:20145152; http://dx.doi.org/10.1158/0008-5472.CAN-09- 3112
48. Galluzzi L, Vitale I, Senovilla L, Olaussen KA, Pinna G, Eisenberg T, et al. Prognostic impact of vitamin B6 metabolism in lung cancer. Cell Rep 2012; 2:257-69; PMID:22854025; http://dx.doi.org/10.1016/j.celrep.2012.06.017